[Form 4] Vita Coco Company, Inc. Insider Trading Activity

Rhea-AI Filing Summary

Jane Prior, Chief Marketing Officer of Vita Coco Company, Inc. (COCO), reported insider activity showing simultaneous option exercise and open-market sales on 09/17/2025. She acquired 10,000 shares at $10.178 per share (Code M) and sold 10,000 shares pursuant to a Rule 10b5-1 trading plan at a weighted average price of $42.043, with sale prices ranging from $42.00 to $42.19. After these transactions she beneficially owned 123,666 shares. The filing lists multiple outstanding non-qualified stock options at various exercise prices and vesting schedules, including 33,750 currently exercisable shares and several tranches vesting through 2035.

Positive

• Transactions executed under a Rule 10b5-1 plan, which provides an affirmative defense regarding trade timing
• Continued substantial holdings: the reporting person retains 123,666 shares after the transactions, indicating ongoing ownership alignment
• Large vested option pool: 33,750 options are currently exercisable, showing available vested equity

Negative

• Disposition of 10,000 shares at a weighted average price of $42.043 reduced the reporting person’s share count by 10,000
• Concentrated future vesting extends through 2035, which may delay full realization of equity value for the reporting person

Insights

Financial Analyst

TL;DR: Insider exercised options at low cost and sold an equal number under a 10b5-1 plan, vesting schedule shows multi-year equity compensation.

The exercise at $10.178 and immediate disposition of 10,000 shares at a weighted average of $42.043 indicates capture of intrinsic value from equity compensation. The reporting person still holds substantial option positions and 123,666 shares post-transaction, leaving continued alignment with shareholders. Transactions were executed under a Rule 10b5-1 plan, reducing concerns about timing. For valuation impact, the realized spread per share was roughly $31.865 based on stated prices, but the filing does not report proceeds or tax treatment.

Corporate Governance Expert

TL;DR: Transactions appear routine and documented; use of 10b5-1 plan supports procedural compliance.

Disclosure shows proper use of an affirmative defense trading plan and the form is signed by an attorney-in-fact, indicating administrative compliance. The mix of fully vested options and long-dated tranches through 2035 reflects standard executive compensation structuring to retain executives. No pledging, transfers to affiliates, or unusual derivative structures are disclosed in this filing.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Prior Jane

(Last) (First) (Middle)

250 PARK AVE SOUTH

SEVENTH FLOOR

(Street)

NEW YORK NY 10003

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Vita Coco Company, Inc. [ COCO ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Marketing Officer

3. Date of Earliest Transaction (Month/Day/Year)
09/17/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/17/2025		M		10,000	A	$10.178	133,666	D
Common Stock	09/17/2025		S(1)		10,000	D	$42.043(2)	123,666	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Non-Qualified Stock Option (right to buy)	$10.178	09/17/2025		M			10,000	(3)	02/10/2030	Common Stock	10,000	$0.0	33,750	D
Non-Qualified Stock Option (right to buy)	$10.178							(4)	12/16/2029	Common Stock	3,675		3,675	D
Non-Qualified Stock Option (right to buy)	$10.178							(5)	01/11/2031	Common Stock	27,300		27,300	D
Non-Qualified Stock Option (right to buy)	$15							(6)	10/21/2031	Common Stock	45,605		45,605	D
Non-Qualified Stock Option (right to buy)	$15.36							(7)	08/15/2032	Common Stock	42,980		42,980	D
Non-Qualified Stock Option (right to buy)	$16.91							(8)	03/10/2033	Common Stock	14,205		14,205	D
Non-Qualified Stock Option (right to buy)	$26.18							(9)	03/04/2034	Common Stock	8,746		8,746	D
Non-Qualified Stock Option (right to buy)	$33.36							(10)	03/04/2035	Common Stock	13,218		13,218	D

Explanation of Responses:

1. The sales of shares of common stock reported were effected pursuant to a Rule 10b5-1 trading plan.

2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.00 to $42.19, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

3. The stock option is fully vested and currently exercisable.

4. The stock option is fully vested and currently exercisable.

5. The stock option is fully vested and currently exercisable.

6. The stock option vests in four equal annual installments beginning on November 27, 2022.

7. The stock option vests in three equal annual installments beginning on August 15, 2025.

8. The stock option vests in four equal annual installments beginning on March 10, 2024.

9. The stock option vests in four equal annual installments beginning on March 4, 2025.

10. The Reporting Person was granted stock options that will vest in four annual equal installments on each anniversary of the grant date provided that the Reporting Person remains in continuous service on each vesting date.

	By: Alison Klein, Attorney-in-Fact For: Jane Prior	09/19/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transactions did COCO insider Jane Prior report on 09/17/2025?

She acquired 10,000 shares at an exercise price of $10.178 (Code M) and sold 10,000 shares under a Rule 10b5-1 plan at a weighted average price of $42.043.

How many COCO shares does Jane Prior beneficially own after the reported trades?

The filing reports that she beneficially owned 123,666 shares following the transactions.

Were the sales made pursuant to a prearranged plan?

Yes. The filing states the sales were effected pursuant to a Rule 10b5-1 trading plan.

What option holdings and vesting schedules are disclosed for Jane Prior?

The form lists multiple non-qualified stock options at exercise prices from $10.178 up to $33.36 with amounts and vesting dates through 2035, and notes several tranches are fully vested and exercisable.

Who signed the Form 4 filing on behalf of Jane Prior?

The form was submitted By: Alison Klein, Attorney-in-Fact for Jane Prior, dated 09/19/2025.